老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Erytech Pharma S.A.

0.7800
0.0000
成交量：- -
成交额：2,727.22
市值：2,661.19万
市盈率：-72.99
高：0.7800
开：0.7800
低：0.7800
收：0.7800
数据加载中...
总览公司新闻公告
2023/03/28

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/23

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/06/30

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/04/27

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/05/07

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/03/09

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/03/08

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/01/29

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/12

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/06

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/10/13

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/10/07

SEC问询函

CORRESP [Cover] - Correspondence
2020/09/22

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/06/25

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/03/18

年度报告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
更多